Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.
Peripheral blood leukocytes, obtained from volunteers after vaccination or natural illness with influenza, were assayed for cytotoxicity against influenza virus-infected cells. Approximately 7 days after vaccination or the onset of respiratory illness, peak cytotoxicity was demonstrated in a chromium-release assay. Secretion of specific antibody against hemagglutinin from the leukocytes during in vitro incubation was demonstrated in quantities that would mediate the cell cytotoxicity observed. Antibody secretion was inhibited by exposure to cycloheximide but not by exposure to trypsin. The secretion of antibody against hemagglutinin from peripheral blood leukocytes occurred only at the time of maximal cytotoxicity. We thus demonstrate secretion of specific antibody in vitro after recent viral antigen stimulation. Moreover, this antibody is capable of conveying cytotoxic capacity to peripheral blood leukocytes that may be important in the recovery process from acute viral infection.
D000914:Antibodies, Viral; D000917:Antibody Formation; D000956:Antigens, Viral; D003513:Cycloheximide / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D006389:Hemagglutinins, Viral; D006801:Humans; D007111:Immunity, Cellular; D007156:Immunologic Memory; D009980:Influenza A virus / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D014357:Trypsin / Q000378:metabolism; D014611:Vaccination; D014765:Viral Vaccines
D000914:Antibodies, Viral; D000956:Antigens, Viral; D006389:Hemagglutinins, Viral; D014765:Viral Vaccines; D003513:Cycloheximide; D014357:Trypsin